321 related articles for article (PubMed ID: 26613856)
21. On the thermotropic and magnetotropic phase behavior of lipid liquid crystals containing magnetic nanoparticles.
Mendozza M; Montis C; Caselli L; Wolf M; Baglioni P; Berti D
Nanoscale; 2018 Feb; 10(7):3480-3488. PubMed ID: 29404545
[TBL] [Abstract][Full Text] [Related]
22. Luteinizing hormone-releasing hormone targeted superparamagnetic gold nanoshells for a combination therapy of hyperthermia and controlled drug delivery.
Mohammad F; Al-Lohedan HA
Mater Sci Eng C Mater Biol Appl; 2017 Jul; 76():692-700. PubMed ID: 28482580
[TBL] [Abstract][Full Text] [Related]
23. Applications and potential toxicity of magnetic iron oxide nanoparticles.
Liu G; Gao J; Ai H; Chen X
Small; 2013 May; 9(9-10):1533-45. PubMed ID: 23019129
[TBL] [Abstract][Full Text] [Related]
24. Superparamagnetic iron oxide nanoparticles for in vivo molecular and cellular imaging.
Sharifi S; Seyednejad H; Laurent S; Atyabi F; Saei AA; Mahmoudi M
Contrast Media Mol Imaging; 2015; 10(5):329-55. PubMed ID: 25882768
[TBL] [Abstract][Full Text] [Related]
25. Reduced astrocyte viability at physiological temperatures from magnetically activated iron oxide nanoparticles.
Schaub NJ; Rende D; Yuan Y; Gilbert RJ; Borca-Tasciuc DA
Chem Res Toxicol; 2014 Dec; 27(12):2023-35. PubMed ID: 25347722
[TBL] [Abstract][Full Text] [Related]
26. The internalization pathway, metabolic fate and biological effect of superparamagnetic iron oxide nanoparticles in the macrophage-like RAW264.7 cell.
Gu J; Xu H; Han Y; Dai W; Hao W; Wang C; Gu N; Xu H; Cao J
Sci China Life Sci; 2011 Sep; 54(9):793-805. PubMed ID: 21922429
[TBL] [Abstract][Full Text] [Related]
27. Shape-, size- and structure-controlled synthesis and biocompatibility of iron oxide nanoparticles for magnetic theranostics.
Xie W; Guo Z; Gao F; Gao Q; Wang D; Liaw BS; Cai Q; Sun X; Wang X; Zhao L
Theranostics; 2018; 8(12):3284-3307. PubMed ID: 29930730
[TBL] [Abstract][Full Text] [Related]
28. Magnetically Enhanced Intracellular Uptake of Superparamagnetic Iron Oxide Nanoparticles for Antitumor Therapy.
Choi J; Kim DI; Kim JY; Pané S; Nelson BJ; Chang YT; Choi H
ACS Nano; 2023 Aug; 17(16):15857-15870. PubMed ID: 37477428
[TBL] [Abstract][Full Text] [Related]
29. Magnetically labeled cells with surface-modified fe3 o4 spherical and rod-shaped magnetic nanoparticles for tissue engineering applications.
Gil S; Correia CR; Mano JF
Adv Healthc Mater; 2015 Apr; 4(6):883-91. PubMed ID: 25641785
[TBL] [Abstract][Full Text] [Related]
30. Magnetic particle imaging: current developments and future directions.
Panagiotopoulos N; Duschka RL; Ahlborg M; Bringout G; Debbeler C; Graeser M; Kaethner C; Lüdtke-Buzug K; Medimagh H; Stelzner J; Buzug TM; Barkhausen J; Vogt FM; Haegele J
Int J Nanomedicine; 2015; 10():3097-114. PubMed ID: 25960650
[TBL] [Abstract][Full Text] [Related]
31. Recent Developments of Magnetic Nanoparticles for Theranostics of Brain Tumor.
Shevtsov M; Multhoff G
Curr Drug Metab; 2016; 17(8):737-744. PubMed ID: 27280470
[TBL] [Abstract][Full Text] [Related]
32. Magneto-plasmonic nanoparticles as theranostic platforms for magnetic resonance imaging, drug delivery and NIR hyperthermia applications.
Urries I; Muñoz C; Gomez L; Marquina C; Sebastian V; Arruebo M; Santamaria J
Nanoscale; 2014 Aug; 6(15):9230-40. PubMed ID: 24980122
[TBL] [Abstract][Full Text] [Related]
33. Single coating of zinc ferrite renders magnetic nanomotors therapeutic and stable against agglomeration.
Venugopalan PL; Jain S; Shivashankar S; Ghosh A
Nanoscale; 2018 Feb; 10(5):2327-2332. PubMed ID: 29326994
[TBL] [Abstract][Full Text] [Related]
34. Multifunctional nano manganese ferrite ferrofluid for efficient theranostic application.
Beeran AE; Fernandez FB; Nazeer SS; Jayasree RS; John A; Anil S; Vellappally S; Al Kheraif AA; Varma PR
Colloids Surf B Biointerfaces; 2015 Dec; 136():1089-97. PubMed ID: 26595389
[TBL] [Abstract][Full Text] [Related]
35. Effect of cell media on polymer coated superparamagnetic iron oxide nanoparticles (SPIONs): colloidal stability, cytotoxicity, and cellular uptake studies.
Petri-Fink A; Steitz B; Finka A; Salaklang J; Hofmann H
Eur J Pharm Biopharm; 2008 Jan; 68(1):129-37. PubMed ID: 17881203
[TBL] [Abstract][Full Text] [Related]
36. Synthesis, characterization and biocompatibility of chitosan functionalized superparamagnetic nanoparticles for heat activated curing of cancer cells.
Thorat ND; Otari SV; Patil RM; Bohara RA; Yadav HM; Koli VB; Chaurasia AK; Ningthoujam RS
Dalton Trans; 2014 Dec; 43(46):17343-51. PubMed ID: 25321385
[TBL] [Abstract][Full Text] [Related]
37. Superparamagnetic iron oxide based nanoprobes for imaging and theranostics.
Lam T; Pouliot P; Avti PK; Lesage F; Kakkar AK
Adv Colloid Interface Sci; 2013 Nov; 199-200():95-113. PubMed ID: 23891347
[TBL] [Abstract][Full Text] [Related]
38. Functionalized superparamagnetic nanoparticles for highly-efficient gene delivery.
Wang X; Chen B; Yang X; Zhang J; Zhao L; Tang J
J Nanosci Nanotechnol; 2013 Feb; 13(2):746-50. PubMed ID: 23646508
[TBL] [Abstract][Full Text] [Related]
39. Shell matters: Magnetic targeting of SPIONs and in vitro effects on endothelial and monocytic cell function.
Matuszak J; Dörfler P; Zaloga J; Unterweger H; Lyer S; Dietel B; Alexiou C; Cicha I
Clin Hemorheol Microcirc; 2015; 61(2):259-77. PubMed ID: 26410877
[TBL] [Abstract][Full Text] [Related]
40. Superparamagnetic iron oxide nanoparticles (SPIONs): from synthesis to in vivo studies--a summary of the synthesis, characterization, in vitro, and in vivo investigations of SPIONs with particular focus on surface and colloidal properties.
Petri-Fink A; Hofmann H
IEEE Trans Nanobioscience; 2007 Dec; 6(4):289-97. PubMed ID: 18217622
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
